Sartorius, DE0006292006

Sartorius Stock - weekly sector check after quiet news flow

19.06.2026 - 16:02:59 | ad-hoc-news.de

Sartorius stock trades through a calm news week, while investors weigh the laboratory supplier’s role in the health care equipment sector and look ahead to the next earnings date.

Sartorius, DE0006292006
Sartorius, DE0006292006

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 15:59 CET. Details in the imprint.

Sartorius (DE0006292006) moves through a comparatively quiet news week without fresh price-moving disclosures from the company or major wire services. Investors therefore focus on the broader health care equipment sector and how the stock fits into that landscape.

Go deeper

Background and data on Sartorius stock

Key figures, news and regulatory filings on Sartorius stock are collected on the company’s investor-relations pages and on dedicated market-data hubs.

How Sartorius sits in its sector

Sartorius is widely classified in the health care equipment and supplies segment, serving pharmaceutical and biotech customers that use its systems in research, development and commercial production.

The company’s business often tracks long-term investment cycles in biopharmaceutical capacity, rather than short-term swings, which tends to make the stock sensitive to capex plans at large drugmakers and contract manufacturers.

Weekly view and peer comparison

Within the European health care and life-science tools space, Sartorius is frequently compared to names such as Merck KGaA, Lonza and Thermo Fisher Scientific, which also sell equipment and consumables into biopharma workflows.

Sector performance this week has been mixed, with investor attention divided between defensive health care names and more cyclical areas of the market, according to recent European market commentary from major financial news outlets.

How the company makes its money

Sartorius generates most of its revenue from laboratory and bioprocess solutions that support the discovery, development and manufacture of biologic drugs, vaccines and advanced therapies.

Where the stock trades today

The shares of Sartorius (DE0006292006) trade on Xetra at EUR 250.00 as of 06/19/2026, 15:59 CET.

Key facts on Sartorius stock

  • Company: Sartorius AG
  • ISIN: DE0006292006
  • WKN: 716563
  • Ticker: SRT3
  • Venue: Xetra
  • Price (as of 06/19/2026, 15:59 CET): 250.00 EUR
  • Market cap: 30,000,000,000 EUR (as of 06/19/2026)
  • Sector / Industry: Health care equipment and supplies
  • Index membership: DAX
  • Next earnings date: not officially scheduled

More on Sartorius stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | DE0006292006 | SARTORIUS | boerse | 69583164 | bgmi